Aurora-A regulation of nuclear factor-κB signaling by phosphorylation of IκBα

被引:93
作者
Briassouli, Paraskevi
Chan, Florence
Savage, Kay
Reis-Filho, Jorge S.
Linardopoulos, Spiros
机构
[1] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW3 6JB, England
[2] Canc Res UK, Inst Canc Res, Ctr Canc Therapeut, Belmont, Surrey, England
关键词
D O I
10.1158/0008-5472.CAN-06-2272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Aurora-A/STK15 gene encodes a kinase that is frequently amplified in cancer. Overexpression of Aurora-A in mammalian cells leads to centrosome amplification, genetic instability, and transformation. In this study, we show that Aurora-A activates nuclear factor-kappa B (NF-kappa B) via I kappa B alpha phosphorylation. Inhibition of endogenous Aurora-A reduces tumor necrosis factor alpha (TNF alpha)-induced I kappa B alpha degradation. We analyzed primary human breast cancers, and 13.6% of samples showed Aurora-A gene amplification, all of which exhibited nuclear localization of NF-kappa B. We propose that this subgroup of patients with breast cancer might benefit from inhibiting Aurora-A. We also show that down-regulation of NF-kappa B via Aurora-A depletion can enhance cisplatin-dependent apoptosis. These data define a new role for Aurora-A in regulating I kappa B alpha that is critical for the activation of NF-kappa B-directed gene expression and may be partially responsible for the oncogenic effect of Aurora-A when the gene is amplified and overexpressed in human tumors.
引用
收藏
页码:1689 / 1695
页数:7
相关论文
共 51 条
  • [1] AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol
    Anand, S
    Penrhyn-Lowe, S
    Venkitaraman, AR
    [J]. CANCER CELL, 2003, 3 (01) : 51 - 62
  • [2] NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
    Bentires-Alj, M
    Barbu, V
    Fillet, M
    Chariot, A
    Relic, B
    Jacobs, N
    Gielen, J
    Merville, MP
    Bours, V
    [J]. ONCOGENE, 2003, 22 (01) : 90 - 97
  • [3] Cloning of STK13, a third human protein kinase related to Drosophila aurora and budding yeast Ipl1 that maps on chromosome 19q13.3-ter
    Bernard, M
    Sanseau, P
    Henry, C
    Couturier, A
    Prigent, C
    [J]. GENOMICS, 1998, 53 (03) : 406 - 409
  • [4] A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
    Bischoff, JR
    Anderson, L
    Zhu, YF
    Mossie, K
    Ng, L
    Souza, B
    Schryver, B
    Flanagan, P
    Clairvoyant, F
    Ginther, C
    Chan, CSM
    Novotny, M
    Slamon, DJ
    Plowman, GD
    [J]. EMBO JOURNAL, 1998, 17 (11) : 3052 - 3065
  • [5] NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
    Biswas, DK
    Shi, Q
    Baily, S
    Strickland, I
    Ghosh, S
    Pardee, AB
    Iglehart, JD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (27) : 10137 - 10142
  • [6] Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
    Cogswell, PC
    Guttridge, DC
    Funkhouser, WK
    Baldwin, AS
    [J]. ONCOGENE, 2000, 19 (09) : 1123 - 1131
  • [7] Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
    Deng, L
    Wang, C
    Spencer, E
    Yang, LY
    Braun, A
    You, JX
    Slaughter, C
    Pickart, C
    Chen, ZJ
    [J]. CELL, 2000, 103 (02) : 351 - 361
  • [8] A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B
    DiDonato, JA
    Hayakawa, M
    Rothwarf, DM
    Zandi, E
    Karin, M
    [J]. NATURE, 1997, 388 (6642) : 548 - 554
  • [9] A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE
    DUDLEY, DT
    PANG, L
    DECKER, SJ
    BRIDGES, AJ
    SALTIEL, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7686 - 7689
  • [10] On the role of aurora-A in centrosome function
    Dutertre, S
    Descamps, S
    Prigent, C
    [J]. ONCOGENE, 2002, 21 (40) : 6175 - 6183